✦ LIBER ✦

The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial

✍ Scribed by H.P. Bhattoa; P. Bettembuk; A. Balogh; G. Szegedi; E. Kiss

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 234 KB
Volume: 15
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-003-1553-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of raloxifene on bone mineral den

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

✍ H. Morii; Y. Ohashi; Y. Taketani; M. Fukunaga; T. Nakamura; A. Itabashi; S. Sark 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

The effect of high-dose vitamin D on bon

The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial

✍ G. Grimnes; R. Joakimsen; Y. Figenschau; P. A. Torjesen; B. Almås; R. Jorde 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 320 KB

Positive effect of alendronate on bone m

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

✍ W. F. Lems; M. C. Lodder; P. Lips; J. W. J. Bijlsma; P. Geusens; N. Schrameijer; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 123 KB

Two-year effects of alendronate on bone

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

✍ Jonathan D. Adachi; Kenneth G. Saag; Pierre D. Delmas; Uri A. Liberman; Ronald D 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

The vitamin D analogue 2MD increases bon

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in